Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impact of Obesity on Postural Control

This study has been completed.
Information provided by:
Université Joseph Fourier Identifier:
First received: April 16, 2010
Last updated: NA
Last verified: April 2010
History: No changes posted
The goal of the present study was to objectively evaluate the postural behaviour of type II obese patients as compared to adults showing a normal body mass index (BMI) in critical postural tasks.

Postural Control
Mechanical Factor

Study Type: Observational
Study Design: Observational Model: Case-Crossover
Time Perspective: Cross-Sectional

Further study details as provided by Université Joseph Fourier:

Study Start Date: April 2010
control (Body Mass Index < 25)
Obese (Body Mass Index > 35)


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Ten healthy non-obese adults (control group, age = 42.4 ± 15.1, BMI = 22.4 ± 1.3, five women and five men) and ten obese adults (obese group, age = 46.2 ± 19.6, BMI = 35.2 ± 2.8, five women and five men, F(1,18)=0.3, p>0.05, and F(1,18)=176.3, p<.001, for control vs. obese age and BMI, respectively) voluntarily took part in this investigation.


  • BMI > 35 or BMI < 25


  • Muscular, neurological or cardiovascular deficits
  • Competitive physical activities
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information Identifier: NCT01106105     History of Changes
Other Study ID Numbers: PCO 
Study First Received: April 16, 2010
Last Updated: April 16, 2010
Health Authority: France: National Consultative Ethics Committee for Health and Life Sciences processed this record on October 25, 2016